As BPA-free bottles started becoming the norm, the Science Market Update published a prophetic article warning about the dangers of the new trend. The article cautioned that BPA substitutes had just as much potential for adverse health effects as the original compound. Recent research from the University of Cincinnati finally provides proof to back up this claim.
Tags: 2014, Midwest, University of Cincinnati, BioResearch Product Faire Event, Cincinnati, OH, UCinci
The University of California, Irvine recently hosted a gala that raised $1.6 million in science research funding for the Chao Family Comprehensive Cancer Center, a part of UC Irvine Health. More than 500 people were in attendance at the event, which was held at Disney’s Grand California Hotel and Spa.
Tags: 2014, CA, Southwest, BioResearch Product Faire Event, Irvine, UCI, UC Irvine, life science research grants, life science research funding
Among Rockefeller University’s new life science funding is a $2.4 million grant from the NIH that will be used to fund a study involving integrating innate and adaptive pathways in vaccine response. The funding organization within the NIH that awarded this life science grant is the National Institute of Allergy and Infectious Diseases, and the project start date was April 1st, 2014.
Tags: 2014, Rockefeller University, Northeast, New York, RockU, BioResearch Product Faire Event, NY, new grant, new funding
A new life science grant awarded by the National Institutes of Health will allow researchers at the University of California, Riverside to better store their life science data and information. The university has received funding of $600,000 from the National Institutes of Health to support data-intensive research.
Tags: 2014, CA, University of California Riverside, California, BioResearch Product Faire Event, Riverside, UC Riverside, new research grants, UCR, life science research funding
Researchers at the University of Texas at Austin have developed a combination of therapies to reduce the growth rate of human cancer.
Tags: 2014, University of Texas, UTAust, Austin, BioResearch Product Faire Event, TX
A running theme in the Science Market Update is that nature seems to have all the answers to our bioscience questions, if only we know how to ask them. For instance, how do we make an anesthetic strong enough to make a scorpion sting painless? And what can we do to keep antibiotics from becoming ineffective? Today’s question, posed by researchers at Michigan State University, is: how can we quickly gather precise water pollution data over entire rivers and lakes? To which nature answers: send in a fleet of water striders.
Tags: Michigan State University, 2014, Midwest, Michigan, BioResearch Product Faire Event, East Lansing, MSU
This month the Knight Cancer Institute at Oregon Health and Science University (OHSU) received a $10 million gift from Columbia Sportswear President and Chief Executive Officer Tim Boyle to recruit and support the next generation of cancer researchers.
Tags: 2014, Oregon Health and Science University, Northwest, BioResearch Product Faire Event, OR, OHSU, Portland
Researchers at Fred Hutchinson Cancer Research Center have discovered that high blood concentrations of omega-3 fatty acids increase risk of prostate cancers. The latest investigations indicate that high concentrations of EPA, DPA, and DHA, which are metabolically related to fatty acids and derived from fatty fish and fish-oil supplements, are associated with a 71% increased risk of high-grade prostate cancer and an overall 43% increase in risk for all prostate cancers.
Tags: 2014, Fred Hutchinson Cancer Research Center, WA, Northwest, BioResearch Product Faire Event, Seattle, Hutch
Researchers at the University of Cincinnati found a therapy for Type 1 diabetes in mouse models. This novel discovery may lead to advancing efforts in combating the disease in humans.
Tags: 2014, University of Cincinnati, BioResearch Product Faire Event, Cincinnati, OH, UCinci
Researchers in the Linus Pauling Institute at Oregon State University discovered a copper compound to form the basis for a therapy for Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig’s disease.
Tags: 2014, Oregon State University, BioResearch Product Faire Event, OR, Corvallis, ORSTU